Zobrazeno 1 - 10
of 66
pro vyhledávání: '"MESH: Fluorouracil"'
Publikováno v:
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, 2022, 88 (11), pp.4928-4932. ⟨10.1111/bcp.15482⟩
British Journal of Clinical Pharmacology, 2022, 88 (11), pp.4928-4932. ⟨10.1111/bcp.15482⟩
International audience; Measuring uracil (U) levels in plasma is a convenient surrogate to establish dihydropyrimidine dehydrogenase (DPD) status in patients scheduled with 5-fluorouracil (5-FU) or capecitabine. To what extent renal impairment could
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2446841dd6e4869e82035b78c64bb9f
https://inria.hal.science/hal-03923650
https://inria.hal.science/hal-03923650
Publikováno v:
B-ENT
B-ENT, 2021, 12 (1), pp.29-32
ResearcherID
Europe PubMed Central
B-ENT, 2021, 12 (1), pp.29-32
ResearcherID
Europe PubMed Central
To preoperatively reduce tumour size in patients with locally advanced and/or non-resectable squamous cell carcinoma with induction chemotherapy in order to achieve surgical excision with clear margins and preserve quality of life.In this study, 16 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b8d339d7f4d1efffb3bc64236ad5fa7c
https://hal.archives-ouvertes.fr/hal-03439029
https://hal.archives-ouvertes.fr/hal-03439029
Toxicity of induction chemotherapy in head and neck cancer: The central role of skeletal muscle mass
Autor:
Alexane Lere‐Chevaleyre, Maureen Bernadach, Céline Lambert, Lucie Cassagnes, Mathilde Puechmaille, Thierry Mom, Laurent Gilain, Michel Lapeyre, Yves Boirie, Julian Biau, Nicolas Saroul
Publikováno v:
Head & Neck
Head & Neck, 2022, 44 (3), pp.681-690. ⟨10.1002/hed.26954⟩
Head & Neck, Wiley, 2022, 44 (3), pp.681-690. ⟨10.1002/hed.26954⟩
Head & Neck, 2022, 44 (3), pp.681-690. ⟨10.1002/hed.26954⟩
Head & Neck, Wiley, 2022, 44 (3), pp.681-690. ⟨10.1002/hed.26954⟩
International audience; Background To assess the impact of nutritional status on tolerance to induction chemotherapy by docetaxel, cisplatin and 5-fluorouracil (ICT) in head and neck cancer (HNC). Methods Ninety-two HNC patients were included. Toxici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab1022a70ba3ac254d1195313be3946d
https://pubmed.ncbi.nlm.nih.gov/34918416
https://pubmed.ncbi.nlm.nih.gov/34918416
Autor:
Anthony, Dohan, Benoit, Gallix, Boris, Guiu, Karine, Le Malicot, Caroline, Reinhold, Philippe, Soyer, Jaafar, Bennouna, Francois, Ghiringhelli, Emilie, Barbier, Valérie, Boige, Julien, Taieb, Olivier, Bouché, Eric, François, Jean-Marc, Phelip, Christian, Borel, Roger, Faroux, Jean-Francois, Seitz, Stéphane, Jacquot, Meher, Ben Abdelghani, Faiza, Khemissa-Akouz, Dominique, Genet, Jean Louis, Jouve, Yves, Rinaldi, Françoise, Desseigne, Patrick, Texereau, Etienne, Suc, Come, Lepage, Thomas, Aparicio, Christine, Hoeffel, Zied, Ladhib
Publikováno v:
Gut
Gut, BMJ Publishing Group, 2020, 69 (3), pp.531-539. ⟨10.1136/gutjnl-2018-316407⟩
Gut, BMJ Publishing Group, 2020, 69 (3), pp.531-539. ⟨10.1136/gutjnl-2018-316407⟩
PurposeThe objective of this study was to build and validate a radiomic signature to predict early a poor outcome using baseline and 2-month evaluation CT and to compare it to the RECIST1·1 and morphological criteria defined by changes in homogeneit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8075364a64f6848b3680bb08f7c9c30
https://doi.org/10.1136/gutjnl-2018-316407
https://doi.org/10.1136/gutjnl-2018-316407
Autor:
Jaafar Bennouna, Christophe Borg, Cécile Badoual, Jean-Baptiste Bachet, Julien Taieb, François Ghiringhelli, Florence Castan, Elie Marcheteau, Sophie Gourgou, Aurélie Cazes, Christelle De La Fouchardiere, Simon Pernot, Olivier Bouché, Trevor Stanbury, Eric Francois, Emmanuelle Samalin, Magali Terme, David Malka, Michel Ducreux
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2017, 79 (8), pp.15-22. ⟨10.1016/j.ejca.2017.03.036⟩
www.sciencedirect.com/science/article/pii/S0959804917308742?via%3Dihub
European journal of cancer (Oxford, England : 1990)
European journal of cancer (Oxford, England : 1990), 2017, 79 (8), pp.15-22. 〈www.sciencedirect.com/science/article/pii/S0959804917308742?via%3Dihub〉. 〈10.1016/j.ejca.2017.03.036〉
European Journal of Cancer, Elsevier, 2017, 79 (8), pp.15-22. ⟨10.1016/j.ejca.2017.03.036⟩
www.sciencedirect.com/science/article/pii/S0959804917308742?via%3Dihub
European journal of cancer (Oxford, England : 1990)
European journal of cancer (Oxford, England : 1990), 2017, 79 (8), pp.15-22. 〈www.sciencedirect.com/science/article/pii/S0959804917308742?via%3Dihub〉. 〈10.1016/j.ejca.2017.03.036〉
IF 6.029; International audience; Background: The identification of dynamic biomarkers in advanced gastric and oesogastric junction adenocarcinoma (GOA) could help to tailor strategies for each patient. Enumeration of circulating tumour cells (CTCs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f7e7b8eaf0bd49d652444adc19c75bd
https://doi.org/10.1016/j.ejca.2017.03.036
https://doi.org/10.1016/j.ejca.2017.03.036
Publikováno v:
Cancer Chemotherapy and Pharmacology
Cancer Chemotherapy and Pharmacology, Springer Verlag, 2019, 83 (1), pp.27-42. ⟨10.1007/s00280-018-3722-5⟩
Cancer Chemotherapy and Pharmacology, 2019, 83 (1), pp.27-42. ⟨10.1007/s00280-018-3722-5⟩
Cancer Chemotherapy and Pharmacology, Springer Verlag, 2019, 83 (1), pp.27-42. ⟨10.1007/s00280-018-3722-5⟩
Cancer Chemotherapy and Pharmacology, 2019, 83 (1), pp.27-42. ⟨10.1007/s00280-018-3722-5⟩
FOLFIRINOX regimen is commonly used in colorectal and more recently pancreatic cancer. However, FOLFIRINOX induces significant and dose-limiting toxic effects leading to empirical dose reduction and sometimes treatment discontinuation. Model-based FO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d15f49c7b034fc0de036e7e82cca4768
https://doi.org/10.1007/s00280-018-3722-5
https://doi.org/10.1007/s00280-018-3722-5
Autor:
C. de la Fouchardière, Marc Ychou, Françoise Desseigne, F. Portales, Caroline Mollevi, S. Iltache, Thibault Mazard, C. Fiess, Antoine Debourdeau, Eric Assenat
Publikováno v:
ESMO Open
ESMO Open, 2021, 6 (6), pp.100318. ⟨10.1016/j.esmoop.2021.100318⟩
ESMO Open, 2021, 6 (6), pp.100318. ⟨10.1016/j.esmoop.2021.100318⟩
Background Nab-paclitaxel/gemcitabine (AG) and FOLFIRINOX (FFX) are promising drugs in metastatic pancreatic cancer (MPC). This study evaluated a new first-line sequential treatment (AG followed by FFX) in MPC that might overcome resistance to primar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05b7f8bb2415f9c13a7733d1658283d9
https://doi.org/10.1016/j.esmoop.2021.100318
https://doi.org/10.1016/j.esmoop.2021.100318
Autor:
Loriot, Marie-Anne, Masskouri, Fadil, Carni, Paolo, Le Malicot, Karine, Seitz, Jean-François, Michel, Pierre, Legoux, Jean-Louis, Bouche, Olivier, André, Thierry, Faroux, Roger, Delaloge, Suzette, Malka, David, Guigay, Joël, Thariat, Juliette, Thomas, Fabienne, Barin-Le-Guellec, Chantal, Ciccolini, Joseph, Boyer, Jean-Christophe, Etienne-Grimaldi, Marie-Christine
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (9), pp.759-775. ⟨10.1016/j.bulcan.2019.04.013⟩
Bulletin du Cancer, 2019, 106 (9), pp.759-775. ⟨10.1016/j.bulcan.2019.04.013⟩
Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (9), pp.759-775. ⟨10.1016/j.bulcan.2019.04.013⟩
Bulletin du Cancer, 2019, 106 (9), pp.759-775. ⟨10.1016/j.bulcan.2019.04.013⟩
International audience; Dihydropyrimidine dehydrogenase (DPD) deficiency is the main cause of early severe toxicities induced by fluoropyrimidines (FP). The French Group of Clinical Oncopharmacology (GPCO)-Unicancer and the French Pharmacogenetics Ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a71787b5bcdf3dd56f31afec496e2a5b
https://hal.archives-ouvertes.fr/hal-02530344/file/S0007455119302255.pdf
https://hal.archives-ouvertes.fr/hal-02530344/file/S0007455119302255.pdf
Autor:
J.N. Vauthey, Binsah George, Kanwal Pratap Singh Raghav, Evelyn Loyer, Michael J. Overman, Scott Kopetz, Leonard B. Saltz, Paulo M. Hoff, Thibault Mazard, Brian P. Hobbs, Wei Qiao, Renata Ferrarotto, Karime Kalil Machado
Publikováno v:
JNCI: Journal of the National Cancer Institute
JNCI: Journal of the National Cancer Institute, Oxford University Press (OUP), 2018, 110 (8), pp.888-894. ⟨10.1093/jnci/djx288⟩
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
JNCI: Journal of the National Cancer Institute, Oxford University Press (OUP), 2018, 110 (8), pp.888-894. ⟨10.1093/jnci/djx288⟩
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
International audience; Background:Oxaliplatin-based chemotherapy can cause hepatic sinusoidal injury (HSI), portal hypertension, and splenic sequestration of platelets. Evidence suggests that bevacizumab may protect against HSI.Methods:Two cohorts o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::220ec46c617e3dc7d6fd4b60d3101131
https://hal.umontpellier.fr/hal-02291196
https://hal.umontpellier.fr/hal-02291196
Autor:
Aparicio , Thomas, Francois , Eric, Cristol-Dalstein , Laurence, Carola , Elisabeth, Maillard , Emilie, Paillaud , Elena, Retornaz , Frédérique, Faroux , Roger, André , Thierry, Bedenne , Laurent, Seitz , Jean-François
Publikováno v:
Digestive and Liver Disease
Digestive and Liver Disease, WB Saunders, 2016, 48 (2), pp.206-7. 〈http://www.sciencedirect.com/science/article/pii/S1590865815301912〉. 〈10.1016/j.dld.2015.11.023〉
Digestive and Liver Disease, WB Saunders, 2016, 48 (2), pp.206-7. ⟨10.1016/j.dld.2015.11.023⟩
Digestive and Liver Disease, WB Saunders, 2016, 48 (2), pp.206-7. 〈http://www.sciencedirect.com/science/article/pii/S1590865815301912〉. 〈10.1016/j.dld.2015.11.023〉
Digestive and Liver Disease, WB Saunders, 2016, 48 (2), pp.206-7. ⟨10.1016/j.dld.2015.11.023⟩
IF 2.719; International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c53f17a4d5be1b81cdfd6502c487830e
https://hal.archives-ouvertes.fr/hal-01437519
https://hal.archives-ouvertes.fr/hal-01437519